Cochlear bags unprecedented revenues, guides for even better 2024
Australian hearing aid manufacturer Cochlear is raking in money, and despite high investment levels, the bottom line is also growing significantly.
Australian Cochlear is scheduled to take over Demant’s implant business later this year and has been in partnership with GN Hearing since 2015.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Demant to divest hearing implant division to Cochlear
For subscribers
